With the capital raised to date, the company has extended its cash runway until the end of the first quarter of 2027.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics Enters Securities Purchase Agreement
- Intensity Therapeutics prices 5M shares at 80c in registered direct offering
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Why Is Intensity Therapeutics Stock (INTS) Up 195% Today?
- Intensity Therapeutics’ INT230-6 antitumor effect featured in published study